IQ Consortium and Allotrope Foundation Discuss Data’s Transformational Role in Pharma!

 Terry Tougas, Chair of the International Consortium on Innovation and Quality in Pharmaceutical Development/IQ Consortium and Gordon Hanson, Chair of the Allotrope Foundation discuss what is going on in the pharmaceutical industry right now to necessitate an event like D4 and how organizations such as the IQ Consortium and the Allotrope Foundation are trying to bring the industry together to standardize data collection and usage.

This podcast includes:

• Can you tell us what is going on in the pharmaceutical industry right now in data integration that fostered the creation of the IQ Consortium and the Allotrope Foundation?
• Each of us has better access to data in our personal lives than we do within our own industry, within our own shop and data that we ourselves generate. And this leads to a tremendous inefficiency requiring tedious manual work and re-work of data and documents….How can we make better use of data that we’ve generated and basically do our job much more efficiently than we are doing today?

For more information about the event download our brochure.

As a reader of the Data-Driven Drug Development (D4) blog, you get a 15% discount off the standard rate when using code XP1715BLOGto to register.. We look forward to seeing you January 28-29 in Philadelphia, PA! If you have any questions about the agenda or event, please contact Kate Devery at kdevery@iirusa.com or visit our webpage.

Wishing you a safe & happy holiday season!
The Data-Driven Drug Development Team
D4 Homepage
D4 Twitter

Share this article with your social network, just click below to share now!

Share |

TH!NK Big Data for the Future of Pharma

After this election it's safe to say 'Big Data' has become a buzzworthy word. But where to next? Last week, Canada's data warehouse, TH!NK announced it will be merging Business Insights and Big Data.

Employing a state-of-the-art, Oracle-based data warehouse, TH!NK will launch its first offering, TH!NK Sales, in January of 2013. This product will track shipment data from manufacturers and wholesalers to pharmacy outlets and hospitals.

This type of collaboration could potentially produce real time data, trend alerts, efficient verification methods, and the ability to access information from many locations. It will offer valuable insights into sales trends and market share with improved speed, reliability and value. Planned future solutions will include prescribing trends, drug utilization insights and related analysis imperative to stakeholders wishing to forecast, monitor resources and plan drug development.

It is an information economy and the Life Science Industry has an abundance of information. With all of the technological advancements, how will big data change the pharmaceutical industry? And how will it help save time?

Using the powerful analytics to take this information to knowledge is a critical success factor for the industry’s future. How has the information become a key weapon in product development? Join us February 6-8 at the Data Driven Drug Development event where Astrazeneca’s Chief Technology Officer, Angela Yochem keynote session, Weapon of Mass Construction: How Life Science Information Management Facilitates Faster and Better Decision Making. For more information download our full brochure here.

As a reader of this blog, you’ll save 15% off the standard rate when you register to join us and mention code XP1715LINK!

Share this article with your social network, just click below to share now!

Share |

Does Your Company Know How to Create a Data Scientist?

Find, Develop and Retain the Information Management and Analytical Talent for Today’s Data-Driven Environment - Your Questions Answered!

Dan Woods, Forbes.com contributor and Editor of Citoresearch.com will address the challenge of the divide between those who know about the new data and who can monetize its value in the presentation “What Is a Data Scientist? Addressing the Challenge of the Divide between Those Who Know about the New Data and Who Can Monetize its Value”

Angela Yochem, CTO, Astrazenca, David Isom, Head, Information Strategy and Analytics, Pfizer, and Sanjoy Ray, Director, Health IT Strategy, Merck headline a senior-level panel and provide best practices for how they are developing the talent and overcoming challenges in the panel presentation “Where is Everybody? Overcome the Challenges Standing in the Way of Finding the Talent.”

This is just a sample of what our agenda has to offer – download the complete agenda to find out more about the program.

Data-Driven Drug Development will take place January 28-29, 2012 in Philadelphia. As a reader of this blog, you’ll save 15% off the standard rate when you register to join us and mention code XP1715BLOG! If you have any questions about the program, feel free to email Jennifer Pereira.

Share this article with your social network, just click below to share now!

Share |